Strs Ohio Vanda Pharmaceuticals Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Strs Ohio holds 41,100 shares of VNDA stock, worth $209,609. This represents 0.0% of its overall portfolio holdings.

Number of Shares

41,100

Previous 41,100 -0.0%

Holding current value

$209,609

Previous $232,000 17.24%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$3.91 - $6.5 $16,422 - $27,300	4,200 Added 11.38%	41,100 $232,000
Q1 2024 May 13, 2024	SELL	$3.47 - $4.61 $73,217 - $97,271	-21,100 Reduced 36.38%	36,900 $151,000
Q2 2023 Jul 31, 2023	BUY	$5.9 - $6.95 $26,550 - $31,275	4,500 Added 8.41%	58,000 $382,000
Q1 2023 Aug 02, 2023	SELL	$6.18 - $7.99 $27,810 - $35,955	-4,500 Reduced 7.76%	53,500 $363,000
Q4 2022 Jan 26, 2023	BUY	$6.87 - $10.96 $54,273 - $86,584	7,900 Added 17.32%	53,500 $395,000
Q2 2022 Jul 25, 2022	BUY	$9.31 - $11.84 $24,206 - $30,784	2,600 Added 6.05%	45,600 $497,000
Q1 2022 Apr 21, 2022	BUY	$10.84 - $16.55 $269,916 - $412,095	24,900 Added 137.57%	43,000 $486,000
Q4 2021 Jan 24, 2022	SELL	$15.69 - $21.14 $10,983 - $14,798	-700 Reduced 3.72%	18,100 $283,000
Q2 2021 Jul 26, 2021	BUY	$15.71 - $21.51 $28,278 - $38,718	1,800 Added 10.59%	18,800 $404,000
Q1 2021 Apr 23, 2021	SELL	$13.42 - $20.28 $193,248 - $292,032	-14,400 Reduced 45.86%	17,000 $255,000
Q4 2020 Jan 25, 2021	SELL	$9.77 - $13.81 $313,617 - $443,301	-32,100 Reduced 50.55%	31,400 $412,000
Q3 2020 Dec 14, 2020	BUY	$9.32 - $12.02 $106,248 - $137,028	11,400 Added 21.88%	63,500 $613,000
Q2 2020 Jul 23, 2020	SELL	$9.66 - $12.02 $57,960 - $72,120	-6,000 Reduced 10.33%	52,100 $596,000
Q1 2020 Apr 23, 2020	BUY	$7.5 - $16.8 $90,000 - $201,600	12,000 Added 26.03%	58,100 $601,000
Q4 2019 Jan 24, 2020	SELL	$12.38 - $17.47 $75,518 - $106,567	-6,100 Reduced 11.69%	46,100 $756,000
Q3 2019 Oct 21, 2019	BUY	$12.27 - $15.79 $17,178 - $22,106	1,400 Added 2.76%	52,200 $693,000
Q2 2019 Jul 25, 2019	BUY	$13.37 - $18.85 $110,971 - $156,455	8,300 Added 19.53%	50,800 $715,000
Q1 2019 Apr 19, 2019	BUY	$17.59 - $31.05 $165,346 - $291,870	9,400 Added 28.4%	42,500 $782,000
Q4 2018 Jan 23, 2019	SELL	$18.97 - $31.47 $149,863 - $248,613	-7,900 Reduced 19.27%	33,100 $864,000
Q3 2018 Oct 19, 2018	SELL	$18.25 - $23.0 $118,625 - $149,500	-6,500 Reduced 13.68%	41,000 $940,000
Q2 2018 Aug 06, 2018	BUY	$13.95 - $19.15 $58,590 - $80,430	4,200 Added 9.7%	47,500 $904,000
Q1 2018 Apr 20, 2018	SELL	$14.05 - $20.2 $181,245 - $260,580	-12,900 Reduced 22.95%	43,300 $729,000
Q4 2017 Jan 23, 2018	BUY	$12.85 - $18.1 $155,485 - $219,010	12,100 Added 27.44%	56,200 $854,000
Q3 2017 Oct 23, 2017	BUY	$15.4 - $18.85 $679,140 - $831,285	44,100	44,100 $789,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.5M

Call Options Held

150K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $288M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account